Document is current
Any future updates will be listed below
-
Authors
Voskrebenzev, Andreas
Kaireit, Till F.
Klein, Marius M.
Kern, Agilo L.
Behrendt, Lea
Klimeš, Filip
Müller, Robin A.
Kayser, Thomas
Wacker, Frank
Vogel-Claussen, Jens
Hohlfeld, Jens M. https://orcid.org/0000-0001-5595-6948
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
Deutsches Zentrum für Lungenforschung
- License Information
-
More Information
Article History
Received: 26 January 2026
Revised: 30 March 2026
Accepted: 19 April 2026
First Online: 20 May 2026
Compliance with ethical standards
:
: The scientific guarantor of this publication is Andreas Voskrebenzev.
: F.K., A.V., and J.V.C. are shareholders of BioVisioneers GmbH, a company that has an interest in pulmonary magnetic resonance imaging methods. M.M. Klein is an employee of BioVisioners GmbH, a company that has an interest in pulmonary magnetic resonance imaging methods. J.M.H.’s institution has received grant support from Boehringer Ingelheim for the conduct of this clinical trial. The remaining authors declare no relevant conflict of interest regarding this submission.
: At least one of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: All examinations were approved by the Ethics Committee of Hannover Medical School.
: This study represents a retrospective subanalysis of a prospective, single-center clinical trial. The trial is registered at ClinicalTrials.gov (NCT04231214).
:
: The authors meet the criteria for authorship as recommended by the ICMJE.
